Corinne Pankovcin - Jun 4, 2021 Form 4 Insider Report for Aditx Therapeutics, Inc. (ADTX)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Corinne Pankovcin
Stock symbol
ADTX
Transactions as of
Jun 4, 2021
Transactions value $
$0
Form type
4
Date filed
6/8/2021, 04:05 PM
Previous filing
May 25, 2021
Next filing
Nov 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADTX Common Stock Award $0 +55K +48.15% $0.00 169K Jun 4, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted common stock vests in three (3) successive equal annual installments, which began on March 31, 2021.